Microfracture, Mosaicplasty or Allograft For The Defect? 

Description

In this informative talk, Vipul Mandalia addresses the complexities of treating chondral and osteochondral defects, elaborating on various treatment options, including microfracture, mosaicplasty, and osteochondral allografts, along with the emerging technique of cartilage transplantation. He emphasizes the importance of assessing the entire osteochondral unit, acknowledging that not all cartilage lesions necessitate treatment. Mandalia discusses the patient-specific factors influencing treatment decisions, such as lesion characteristics, patient demographics, and rehabilitation compliance. He provides an overview of the outcomes of microfracture, highlighting its short-term benefits but long-term limitations, especially in younger patients who might require future interventions. Mosaicplasty is presented as a more favorable option due to the use of autologous hyaline cartilage, with its challenges primarily revolving around lesion size. Finally, Mandalia introduces osteochondral allografts as an effective solution for larger defects while discussing the regulatory hurdles faced in cartilage transplantation following Brexit. He concludes with a summary of each treatment’s utility, underscoring the importance of tailored treatment approaches and the ongoing efforts to navigate current challenges in cartilage repair.

DOI: 10.1302/3114-221656

Specialties